Spots Global Cancer Trial Database for DLSCT for Breast Cancer Detection in Women With Dense Breasts
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: DLSCT for Breast Cancer Detection in Women With Dense Breasts
Official Title: Dual-layer Spectral Computerized Tomography for Breast Cancer Detection in Women With Dense Breasts: a Single Centre, Feasibility Study - The DECREAS Study
Study ID: NCT05181059
Interventions
Study Description
Brief Summary: The main objective of this project is to demonstrate the feasibility of DLSCT to detect breast cancer in women with dense breasts. Patients with locoregional advanced primary breast cancer and heterogeneously (n = 7) or extremely dense breasts (n = 7) as determined by mammography will be included in this study. These patients have an indication for a positron emission tomography computed tomography (PET-CT) scan to search for distant metastases. In this study the participants will undergo an additional contrast enhanced DLSCT scan to determine the feasibility of spectral CT to detect breast cancer in women with dense breasts.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Rijnstate Hospital, Arnhem, , Netherlands
Contact Details
Name: Laura N Deden
Affiliation: Rijnstate Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Maxime V.P. Schyns, MD
Affiliation: Rijnstate Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
